安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
MMPI-1154 是一种很有前景的,新型心肌细胞保护咪唑-羧酸 MMP-2 抑制剂 (IC50=6.6 μM),可用于急性心肌梗死的研究。MMPI-1154 也抑制 MMP-13、MMP-1 和 MMP-9 的活性,其 IC50 分别为 1.8 μM、10 μM、13 μM。
MMPI-1154 is a promising novel cardio-cytoprotective imidazole-carboxylic acid (ICA) MMP-2 inhibitor(IC50=6.6 μM) and can be used for the study of acute myocardial infarction. MMPI-1154 also inhibits the activity of MMP-13, MMP-1 and MMP-9 with IC50s of 1.8 μM,10 μM, and 13 μM, respectively[1].
[1]. Péter Bencsik, et al. Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection.Front Pharmacol. 2018 Apr 5;9:296.
动态评分
0.0